Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK

By Sidhu M. K.   van Engen A. K.   Kleintjens J.   Schoeman O.   Palazzo M.  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 2049-2059

Informa Healthcare

Access to resources Recommend Favorite

De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study

By Mokart Djamel   Slehofer Géraldine   Lambert Jérôme   Sannini Antoine   Chow-Chine Laurent   Brun Jean-Paul   Berger Pierre   Duran Ségolène   Faucher Marion   Blache Jean-Louis   Saillard Colombe   Vey Norbert   Leone Marc  

Intensive Care Medicine, Vol. 40, Iss. 1, 2014-01 ,pp. : 41-49

Springer Publishing Company

Access to resources Recommend Favorite

What can be expected from antimicrobial de-escalation in the critically ill?

By Kollef Marin  

Intensive Care Medicine, Vol. 40, Iss. 1, 2014-01 ,pp. : 92-95

Springer Publishing Company

Access to resources Recommend Favorite

Use of CHROMagar medium in the differentiation of Candida species: is it cost-effective in developing countries?

By Iyampillai T.   Michael J. S.   Mathai E.   Mathews M. S.  

Annals of Tropical Medicine and Parasitology, Vol. 98, Iss. 3, 2004-04 ,pp. : 279-282

Maney Publishing

Access to resources Recommend Favorite

Supplement: Trends in invasive Candida infections and their treatment: focus on echinocandins

By  

Current Medical Research and Opinion, Vol. 25, Iss. 7, 2009-07 ,pp. : 1729-1762

Informa Healthcare

Access to resources Recommend Favorite